1.
Zheng ZN, Shen XH, Ye XB, Li T, Guo J. Advances in Targeted Therapy for Human Epidermal Growth Factor Receptor 2-Low Tumors: From Trastuzumab to Antibody-Drug Conjugates. World J Oncol. 2026;17(2):129-142. doi:10.14740/wjon2718